Literature DB >> 24420340

Right ventricular function in late-onset Pompe disease.

Abdallah Fayssoil1, Olivier Nardi, Djillali Annane, David Orlikowski.   

Abstract

Pompe's disease is a glycogen storage disease (type II) characterized by inherited autosomal recessive transmission. The right ventricular (RV) function is a determinant parameter of clinical outcome in patients with heart failure. We sought to characterize the RV function using Doppler-echocardiography completed by Doppler tissular imaging and tricuspid annular plane systolic excursion (TAPSE) measurement. We analyzed retrospectively clinical and Doppler-echocardiographic data of patients with adult late onset Pompe disease and compared to a control group. Ten patients with late onset Pompe disease were included in our study and were compared to a control group (seven patients). Mean age was 56.7 ± 10.2 years in late onset Pompe disease versus 55 ± 21 years in control group (p  = 0.65). Left ventricular ejection fraction (LVEF) was similar in the two groups (LVEF 63.7 ± 9 vs 63.7 ± 6.6 % in control group p  = 0.99). LV end diastolic diameter was 40.8 ± 6 mm in Pompe disease versus 45.8 ± 6 mm in control group (p  = 0.11). Mean TAPSE was similar in the two groups (25.6 ± 6.2 vs 21.5 ± 2.7 mm p = 0.23). Mean peak systolic RV velocity Sm was not significantly different in the two groups (17.11 ± 3.4 cm/s in Pompe disease vs 16.14 ± 3.8 cm/s in control group p = 0.61). Mean peak early diastolic Ea velocity in the RV were not significantly different in the two groups (15.6 ± 5.6 vs 18.2 ± 4.9 cm/s p = 0.34). According to our data, RV systolic function seems preserved in late-onset Pompe disease.

Entities:  

Mesh:

Year:  2014        PMID: 24420340     DOI: 10.1007/s10877-014-9551-0

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  10 in total

1.  The Mount Sinai Hospital clinicalpathological conference: a 45-year-old man with Pompe's disease and dilated cardiomyopathy.

Authors:  R Ben-Ami; J Puglisi; T Haider; D Mehta
Journal:  Mt Sinai J Med       Date:  2001-05

Review 2.  Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function.

Authors:  T H Marwick
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 3.  Echocardiography in the assessment of right heart function.

Authors:  Per Lindqvist; Avin Calcutteea; Michael Henein
Journal:  Eur J Echocardiogr       Date:  2008-03

4.  Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo-derived right ventricular ejection fraction.

Authors:  Stefano De Castro; Elena Cavarretta; Alberto Milan; Stefano Caselli; Emanuele Di Angelantonio; Dario Vizza Carmine; Diego Lucchetti; Ayan Patel; Jeffrey Kuvin; Natesa G Pandian
Journal:  Echocardiography       Date:  2008-03       Impact factor: 1.724

5.  Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome.

Authors:  B H Bulkley; G M Hutchins
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

Review 6.  [Echocardiography in storage and neuromuscular disorders].

Authors:  C Stöllberger; J Finsterer
Journal:  Wien Klin Wochenschr       Date:  2001-06-15       Impact factor: 1.704

7.  Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

Authors:  S Ghio; F Recusani; C Klersy; R Sebastiani; M L Laudisa; C Campana; A Gavazzi; L Tavazzi
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

8.  Right ventricular outflow-tract fractional shortening: an applicable measure of right ventricular systolic function.

Authors:  P Lindqvist; M Henein; E Kazzam
Journal:  Eur J Echocardiogr       Date:  2003-03

9.  Cardiac involvement in adults with Pompe disease.

Authors:  O I I Soliman; N A M E van der Beek; P A van Doorn; W B Vletter; A Nemes; B M Van Dalen; F J ten Cate; A T van der Ploeg; M L Geleijnse
Journal:  J Intern Med       Date:  2008-04-04       Impact factor: 8.989

10.  Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.

Authors:  Daniel Forsha; Jennifer S Li; P Brian Smith; Ans T van der Ploeg; Priya Kishnani; Sara K Pasquali
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

  10 in total
  2 in total

Review 1.  Year in review in journal of clinical monitoring and computing 2014: cardiovascular and hemodynamic monitoring.

Authors:  Karim Bendjelid; Steffen Rex; Thomas Scheeren; Lester Critchley
Journal:  J Clin Monit Comput       Date:  2015-03-05       Impact factor: 2.502

2.  Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.

Authors:  Daniel A Morris; Daniela Blaschke; Alice Krebs; Sima Canaan-Kühl; Ursula Plöckinger; Gesine Knobloch; Thula C Walter; York Kühnle; Leif-Hendrik Boldt; Elisabeth Kraigher-Krainer; Burkert Pieske; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-06       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.